Stay updated on Pembrolizumab and Radiation in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page.
Latest updates to the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision update from v3.4.1 to v3.4.2. No visible changes to the study details or page layout were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check19 days agoChange DetectedA new publication citation by Chen D. et al. (J Immunother Cancer, 2020) was added to Publications, and the Erratum entry for the earlier paper was removed with the revision updated to v3.4.1.SummaryDifference0.1%
- Check28 days agoChange DetectedAdded a Show glossary option and updated Study Record Dates with Last Update Submitted that Met QC Criteria and Last Update Posted, along with No FEAR Act Data and revision to v3.4.0. These changes are administrative and do not alter study details or outcomes.SummaryDifference0.2%
- Check42 days agoChange DetectedResults Submitted appeared on the page and the revision was updated to v3.3.4. The previously listed No Results Posted and Revision: v3.3.3 were removed.SummaryDifference0.1%
- Check49 days agoChange DetectedAdded the J Immunother Cancer 2020 publication by Chen et al. (with erratum) to the Publications section and deleted the previous listing of that article.SummaryDifference0.0%
- Check64 days agoChange DetectedAdded a Locations section listing Texas as a location and removed the previous Texas Locations entry.SummaryDifference0.2%
Stay in the know with updates to Pembrolizumab and Radiation in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page.